ANPAC Bio-Medical launching new facility in California.
Anpac China
China
Anpac Bio in the News

Anpac Bio Surpasses 40,000 Case Study Milestone ‘Liquid Biopsy Pioneer’ Serving Individual, Medical, Insurance & Corporate Customers.

SACRAMENTO, Calif., March 28, 2017 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting over 40,000 cases worldwide of the company's proprietary, "Cancer Differentiation ...

Anpac Bio proud to sponsor the inaugural ‘Anpac Bio World Youth Innovation Forum’, at 2016 World Nobel Prize Laureate Summit, featuring the theme”Serendipity in Science”

Seven Nobel Prize Laureates and over 20 internationally acclaimed researchers and scientists, are presenting at the third annual, "World Nobel Prize Laureate Summit" in Chengdu, China, September 2-3, 2016. The 2016 WNPLS' will feature three programs of scientific exploration: 1) "Anpac Bio World Youth Innovation ...

Anpac Bio CEO Keynote Speaker at UC Biomedical & Engineering Entrepreneurship Academy

SACRAMENTO, Calif., July 8, 2016  -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, will deliver the Keynote Address to award-winning life and technical science students, faculty, administration, corporate partners, officials, and general public, to launch the University of ...

Anpac Bio-Medical Science Pledges $50,000 to UC Davis ChildFamily Institute for innovation and Entrepreneurship

Anpac Fellowships Underwrite University of California Students to Attend Scientific Innovation Academies SACRAMENTO, Calif., Jan. 7, 2016 -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, has pledged $50,000 to the University of California, Davis Child Family Institute for ...

Anpac Bio Receives ‘Series B’ Funding”

Anpac Bio Receives 'Series B' Funding from Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors Strategic Backers Increase Investment in Successful 'Blood Biopsy' Technology SACRAMENTO, Calif., Dec. 24, 2015 /PRNewswire/ -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu ...

Anpac Bio-Medical Presenting ‘Breakthrough’ Cancer Screening Tech/Research At Breast Cancer Symposium

SACRAMENTO, Calif., Sept. 16, 2015 -- Anpac Bio-Medical Science Company Chief Executive Officer Dr. Chris Yu and Anpac scientists will be presenting "breakthrough," Breast Cancer screening and early detection research results at the upcoming "Breast Cancer Symposium" in San Francisco, California, September 25-27, 2015. Reporting ...

Anpac Bio-Medical Successfully Achieves Series A Funding

Anpac Bio-Medical Successfully Achieves Series A Funding from Shanghai Zhangjiang Science & Technology Investment CorporationRespected Tech VC Enthusiastic about 'Breakthrough' Early Cancer Detection 'Blood Biopsy' SACRAMENTO, Calif., Aug. 18, 2015 -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced this week that highly-respected ...

Anpac Bio-Medical Introduces ‘Game Changing’ Cancer Screening Tech at American Society of Clinical Oncology Meeting

Anpac Bio discloses 'Breakthrough' Early Cancer Detection 'Blood Biopsy' SACRAMENTO, Calif., May 29, 2015 -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) ...

‘2015 Nobel Prize Laureate Summit on Biomedical Science: Frontiers in Cancer Research’

Five Nobel Laureates & World's Top Researchers Exchange Cancer Breakthroughs TIANJIN, China, May 14, 2015 -- Five Nobel Prize Laureate's and the world's top scientists met this week in Tianjin, China, for an unprecedented Summit, exchanging research data, advances, and promising projections related to the prevention, ...

Anpac Bio-Medical Presented ‘Cancer Differentiation Analysis’” “Research at ‘2015 Nobel Prize Laureate Summit on Biomedical” “Science”

SACRAMENTO, Calif., May 13, 2015 -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu this week presented what event organizers published as, "very promising" and "breakthrough" early cancer detection technology research results at the "2015 Nobel Prize Laureate Summit on ...